DGAP-News: Burcon NutraScience Corp.: Burcon Sees CLARISOY Commercialization Ramping up in 2013
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: Burcon Sees CLARISOY Commercialization
Ramping up in 2013
25.04.2013 / 12:39
---------------------------------------------------------------------
Burcon Sees CLARISOY Commercialization Ramping up in 2013
On the heels of a third patent, global food and beverage markets continue
to have strong interest in CLARISOY(TM)
Vancouver, British Columbia, April 24, 2013- Burcon NutraScience
Corporation (TSX :BU, NASDAQ:BUR), a leader in functional, renewable plant
proteins, reported that with the third U.S. patent being granted for a
process used to produce CLARISOY soy protein, its manufacturing and
marketing partner for its CLARISOY soy protein, Archer Daniels Midland
Company, continues to see development activities from the global food and
beverage market.
A key step in the commercialization of a revolutionary food ingredient like
CLARISOY is to produce commercially produced samples for food and beverage
manufacturers who will use the samples to develop prototypes, perform
essential product testing, complete shelf-life studies, and conduct
consumer focus-groups before commercially launching a product. Due to the
lengthy product development cycle for major brands, Burcon expects to
report royalty payments for the quarter ended March 31, 2013 to again be
minimal.
'CLARISOY is a truly innovative ingredient for food and beverage
manufacturers seeking to incorporate a transparent protein in their
products,' said Johann F. Tergesen, Burcon's president and COO. 'We
recognize that the development process for major branded food and beverage
products involves extensive time and investment. We are encouraged by the
substantial inroads ADM has made for CLARISOY in the food and beverage
market. We're looking forward to the continued market development
activities with CLARISOY in 2013, as Burcon works to further strengthen the
valuable IP surrounding this unique protein technology.'
Burcon was recently awarded its third U.S. patent within the last two
months for processes used to produce CLARISOY soy protein. Its patent
portfolio now consists of 225 issued patents in various countries,
including 39 in the U.S., as well as more than 400 active patent
applications, including 80 additional U.S. patent applications.
About CLARISOY Soy Protein
CLARISOY soy protein is the world's first vegetable-based protein capable
of offering both clarity and high-quality protein nutrition in low pH
beverage systems. CLARISOY is under exclusive license to Archer Daniels
Midland Company (ADM), which offers a range of products for both low and
neutral pH applications, allowing food and beverage companies to easily
include up to 10 grams of CLARISOY per 500mL serving.
ADM's CLARISOY-based products include CLARISOY 100, a premier
vegetable-based protein that offers both clarity and high-quality protein
nutrition for beverages with a pH of less than four. Extremely heat stable,
CLARISOY 100 requires no homogenization or stabilizers in low pH beverages.
It is specifically designed to enable beverage manufacturers to meet the
demand for great-tasting, nutritionally enhanced beverages by the growing
number of health and wellness oriented consumers. Applications include
sport nutrition beverages, citrus-based drinks, fruit-flavored beverages,
fruit-juice blends, lemonades, powdered beverage mixes and fortified
waters.
CLARISOY 150 is a revolutionary soy protein for neutral pH beverages and
low pH beverages with cloud systems. The clean flavor and smooth mouth-feel
makes CLARISOY 150 a formulator's ideal protein ingredient.
For more information about CLARISOY, go to www.clarisoy.com
About Burcon NutraScience Corporation
Burcon NutraScience is a leader in nutrition, health and wellness in the
field of functional plant proteins. The company has developed a portfolio
of composition, application, and process patents originating from a core
protein extraction and purification technology. Burcon has developed:
CLARISOY(TM) soy protein - now licensed to Archer Daniels Midland Company -
which offers clarity and high-quality protein nutrition for low pH beverage
systems and exceptionally clean flavor at any pH; Peazazz(TM) a uniquely
soluble and clean-tasting pea protein; and Puratein(R), Supertein(TM) and
Nutratein(TM) are canola protein isolates with unique functional and
nutritional attributes. For more information about the company, visit
www.burcon.ca
ON BEHALF OF THE BOARD OF DIRECTORS
'Johann F. Tergesen'
Johann F. Tergesen
President&Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking statements. All statements
other than statements of historical fact included in this release are
forward-looking statements, including, without limitation, statements
regarding plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release. There can be no assurance that such statements will prove to
be accurate and actual results and future events could differ materially
from those anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon's plans
and expectations include the actual results of marketing activities,
adverse general economic, market or business conditions, regulatory changes
and other risks and factors detailed herein and from time to time in the
filings made by Burcon with securities regulators and stock exchanges,
including in the section entitled 'Risk Factors' in Burcon's annual
information form dated June 25, 2012. Any forward-looking statement or
information only speaks as of the date on which it was made and, except as
may be required by applicable securities laws, Burcon disclaims any intent
or obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance and accordingly undue reliance should not be put on such.
Media&Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896
(888) 408-7960 toll-free
mkirwan(at)burcon.ca www.burcon.ca
Investor Relations Contact:
John MacLennan
Managing Director
Liolios Group, Inc.
Tel (416) 644.8688
john(at)liolios.com
###
End of Corporate News
---------------------------------------------------------------------
25.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
208541 25.04.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.04.2013 - 12:39 Uhr
Sprache: Deutsch
News-ID 252791
Anzahl Zeichen: 9243
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: Burcon Sees CLARISOY Commercialization Ramping up in 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
